insights_auto
Why is CHGCF down 2.73%?
Dive Deeperchevron_right
CHGCF:OTCMKTS
Chugai Pharmaceutical Co Ltd
$36.66
arrow_downward
-2.73%(-1.03) 1D
Oct 12, 9:41:38 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCF...
Open
$36.66
High
$36.66
Low
$36.66
Mkt. cap
10.11T
Avg. vol.
11.30K
Volume
468.00
52-wk high
$68.08
52-wk low
$34.79
Beta
1.91
Shares outstanding
1.68B
No. of employees
5K
Open
$36.66
High
$36.66
Low
$36.66
Mkt. cap
10.11T
Avg. vol.
11.30K
Volume
468.00
52-wk high
$68.08
52-wk low
$34.79
Beta
1.91
Shares outstanding
1.68B
No. of employees
5K
News stories
From web sources and news partners
ad-hoc-news.de
·
7 hours ago
Citi keeps Buy rating for Chugai Pharmaceutical stock at JPY 11,100.00
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp